151 related articles for article (PubMed ID: 35034388)
1. Safety and effectiveness of do-it-yourself artificial pancreas system compared with continuous subcutaneous insulin infusions in combination with free style libre in people with type 1 diabetes.
Patel R; Crabtree TSJ; Taylor N; Langeland L; Gazis AT; Mendis B; Wilmot EG; Idris I
Diabet Med; 2022 May; 39(5):e14793. PubMed ID: 35034388
[TBL] [Abstract][Full Text] [Related]
2. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
[TBL] [Abstract][Full Text] [Related]
3. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.
Deshmukh H; Wilmot EG; Gregory R; Barnes D; Narendran P; Saunders S; Furlong N; Kamaruddin S; Banatwalla R; Herring R; Kilvert A; Patmore J; Walton C; Ryder REJ; Sathyapalan T
Diabetes Care; 2020 Sep; 43(9):2153-2160. PubMed ID: 32669277
[TBL] [Abstract][Full Text] [Related]
4. The long-term impact of glucose monitoring with the FreeStyle Libre on glycaemic control and hypoglycaemia awareness in people with type 1 diabetes: Insights from the Association of British Clinical Diabetologists national audit.
Shah N; Deshmukh H; Wilmot EG; Patmore J; Christian P; Barnes DJ; Walton C; Ryder REJ; Sathyapalan T
Diabet Med; 2023 Jun; 40(6):e15070. PubMed ID: 36797537
[TBL] [Abstract][Full Text] [Related]
5. Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: Online Survey and Analysis of Self-Reported Clinical Outcomes.
Braune K; O'Donnell S; Cleal B; Lewis D; Tappe A; Willaing I; Hauck B; Raile K
JMIR Mhealth Uhealth; 2019 Jul; 7(7):e14087. PubMed ID: 31364599
[TBL] [Abstract][Full Text] [Related]
6. Predictors of diabetes-related distress before and after FreeStyle Libre-1 use: Lessons from the Association of British Clinical Diabetologists nationwide study.
Deshmukh H; Wilmot EG; Gregory R; Barnes D; Narendran P; Saunders S; Furlong N; Kamaruddin S; Banatwalla R; Herring R; Kilvert A; Patmore J; Walton C; Ryder REJ; Sathyapalan T
Diabetes Obes Metab; 2021 Oct; 23(10):2261-2268. PubMed ID: 34142425
[TBL] [Abstract][Full Text] [Related]
7. Time in range following flash glucose monitoring: Relationship with glycaemic control, diabetes-related distress and resource utilisation in the Association of British Clinical Diabetologists national audit.
Deshmukh H; Wilmot E; Pieri B; Choudhary P; Shah N; Gregory R; Kilvert A; Lumb A; Christian P; Barnes D; Patmore J; Walton C; Ryder REJ; Sathyapalan T
Diabet Med; 2022 Nov; 39(11):e14942. PubMed ID: 36054655
[TBL] [Abstract][Full Text] [Related]
8. Continuous subcutaneous insulin infusion (CSII) therapy at Derby Teaching Hospitals: sustained benefits in glucose control.
Anyanwagu U; Olaoye H; Jennings P; Ashton-Cleary S; Sugunendran S; Hughes D; Idris I; Wilmot EG
Diabet Med; 2017 Aug; 34(8):1154-1157. PubMed ID: 28430381
[TBL] [Abstract][Full Text] [Related]
9. Continuous Subcutaneous Insulin Infusion in Adult Type 1 Diabetes Mellitus Patients: Results from a Public Health System.
Moreno-Fernandez J; Gomez FJ; Pinés P; González J; López J; López LM; Blanco B; Roa C; Herranz S; Muñoz-Rodríguez JR
Diabetes Technol Ther; 2019 Aug; 21(8):440-447. PubMed ID: 31199682
[No Abstract] [Full Text] [Related]
10. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c.
Żurawska-Kliś M; Kosiński M; Kuchnicka A; Rurka M; Hałucha J; Wójcik M; Cypryk K
Diabetes Res Clin Pract; 2021 Feb; 172():108628. PubMed ID: 33358970
[TBL] [Abstract][Full Text] [Related]
11. Using a Do-It-Yourself Artificial Pancreas: Perspectives from Patients and Diabetes Providers.
Palmer W; Greeley SAW; Letourneau-Freiberg LR; Naylor RN
J Diabetes Sci Technol; 2020 Sep; 14(5):860-867. PubMed ID: 32680447
[TBL] [Abstract][Full Text] [Related]
12. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
[TBL] [Abstract][Full Text] [Related]
13. Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
Jeyam A; Gibb FW; McKnight JA; Kennon B; O'Reilly JE; Caparrotta TM; Höhn A; McGurnaghan SJ; Blackbourn LAK; Hatam S; McCrimmon RJ; Leese G; Lindsay RS; Petrie J; Chalmers J; Philip S; Wild SH; Sattar N; McKeigue PM; Colhoun HM;
Diabetologia; 2021 Jun; 64(6):1320-1331. PubMed ID: 33686483
[TBL] [Abstract][Full Text] [Related]
14. Budget impact of continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes who experience severe recurrent hypoglycemic episodes in Spain.
Giménez M; Elías I; Álvarez M; Quirós C; Conget I
Endocrinol Diabetes Nutr; 2017; 64(7):377-383. PubMed ID: 28745609
[TBL] [Abstract][Full Text] [Related]
15. HbA
Evans-Cheung TC; Campbell F; Yong J; Parslow RC; Feltbower RG
Diabet Med; 2019 Jan; 36(1):88-95. PubMed ID: 30059173
[TBL] [Abstract][Full Text] [Related]
16. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort Study.
Abell SK; Suen M; Pease A; Boyle JA; Soldatos G; Regan J; Wallace EM; Teede HJ
Diabetes Technol Ther; 2017 May; 19(5):280-287. PubMed ID: 28282241
[TBL] [Abstract][Full Text] [Related]
18. Multiple basal infusion rates in open-loop insulin delivery systems: is there a metabolic benefit?
Sá JM; Lopes SC; Santos MJ; Alves M; Lages AS
Arch Endocrinol Metab; 2024 Feb; 68():e230055. PubMed ID: 38394157
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, safety, and user experience of DIY or open-source artificial pancreas systems: a systematic review.
Asarani NAM; Reynolds AN; Elbalshy M; Burnside M; de Bock M; Lewis DM; Wheeler BJ
Acta Diabetol; 2021 May; 58(5):539-547. PubMed ID: 33128136
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Effects of Continuous Subcutaneous Insulin Infusion on Glucose Control and Microvascular Complications in Patients With Type 1 Diabetes.
Marchand L; Kawasaki-Ogita Y; Place J; Fayolle C; Lauton D; Boulet F; Farret A; Renard E
J Diabetes Sci Technol; 2017 Sep; 11(5):924-929. PubMed ID: 28303725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
